Related Experiment Video
Updated: Aug 11, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Long-term adaptive changes induced by serotonergic antidepressant drugs
Céline Faure1, Ouissame Mnie-Filali, Nasser Haddjeri
1Laboratoire de Neuropharmacologie et Neurochimie, Faculté de Pharmacie, Université Claude Bernard, Lyon 1, EA-512, 8, Avenue Rockefeller, 69373 Lyon Cedex 08, France. cfaure@sante.univ-lyon1.fr
Expert Review of Neurotherapeutics
|February 10, 2006
Summary
Conventional antidepressants target the serotonin (5-hydroxytryptamine, 5-HT) system. New research explores how 5-HT function and hippocampal neuroplasticity impact major depressive disorder, potentially revealing novel treatment strategies.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Conventional antidepressants primarily target the serotonin (5-hydroxytryptamine, 5-HT) system, aligning with the monoaminergic hypothesis of depression.
- The delayed therapeutic effect of these antidepressants is linked to adaptive changes in functional 5-HT receptors.
- Emerging theories propose that major depressive disorders involve impairments in functional plasticity and cellular flexibility.
Purpose of the Study:
- To review physiological mechanisms regulating 5-HT function.
- To discuss the regulation of hippocampal neuroplasticity.
- To explore how understanding these adaptations can inform new antidepressant strategies.
Main Methods:
- Literature review of physiological mechanisms.
- Analysis of current theories on depression and neuroplasticity.
- Synthesis of information on 5-HT system regulation.
Main Results:
- 5-HT neurotransmission is modulated by complex adaptive changes in receptor function.
- Hippocampal neuroplasticity is a key factor in affective disorders.
- Long-term adaptations in 5-HT function and neuroplasticity are crucial for therapeutic effects.
Conclusions:
- Understanding the interplay between 5-HT and neuroplasticity is vital for elucidating depression pathophysiology.
- This knowledge may pave the way for novel therapeutic interventions targeting cellular flexibility and plasticity.
- Future research should focus on the long-term adaptive mechanisms of the 5-HT system and neuroplasticity in depression.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...